Fragmented QRS on twelve-lead electrocardiogram predicts arrhythmic events in patients with ischemic and nonischemic cardiomyopathy

Heart Rhythm

Volumn 7, Issue 1, 2010, Pages 74-80

  Das, Mithilesh Kumar ^a   Maskoun, Waddah ^a   Shen, Changyu ^b   Michael, Mark A ^a   Suradi, Hussam ^a   Desai, Mona ^a   Subbarao, Roopa ^a   Bhakta, Deepak ^a  

^a VETERANS AFFAIRS MEDICAL CENTER   (United States)

^b INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Arrhythmic event; Fragmented QRS; Mortality

Indexed keywords

ADULT; AGED; ARTICLE; CARDIOMYOPATHY; CONGESTIVE CARDIOMYOPATHY; CONTROLLED STUDY; DEFIBRILLATOR; ECG ABNORMALITY; ELECTROCARDIOGRAM; EVENT FREE SURVIVAL; FEMALE; FOLLOW UP; FRAGMENTED QRS; HEART DEATH; HEART VENTRICLE ARRHYTHMIA; HUMAN; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; MALE; MORTALITY; PREDICTION; PRIMARY PREVENTION; PRIORITY JOURNAL; PROGNOSIS; QRS COMPLEX; R WAVE; RETROSPECTIVE STUDY; SECONDARY PREVENTION; ST SEGMENT;

AGED; ARRHYTHMIAS, CARDIAC; CARDIOMYOPATHY, DILATED; CONFIDENCE INTERVALS; CORONARY ARTERY DISEASE; DEFIBRILLATORS, IMPLANTABLE; ELECTROCARDIOGRAPHY; FEMALE; HEART CONDUCTION SYSTEM; HUMANS; INCIDENCE; INDIANA; MALE; MIDDLE AGED; PRIMARY PREVENTION; PROGNOSIS; RETROSPECTIVE STUDIES; RISK FACTORS; SECONDARY PREVENTION;

EID: 72449189681     PISSN: 15475271     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.hrthm.2009.09.065     Document Type: Article

References (40)

1. A comparison of antiarrhythmic-drug therapy with implantable defibrillators in patients resuscitated from near-fatal ventricular arrhythmias. The Antiarrhythmics versus Implantable Defibrillators (AVID) Investigators. N Engl J Med 337 (1997) 1576-1583
2. Bardy G.H., Lee K.L., Mark D.B., et al. Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure. N Engl J Med 352 (2005) 225-237
3. Kadish A., Dyer A., Daubert J.P., et al. Prophylactic defibrillator implantation in patients with nonischemic dilated cardiomyopathy. N Engl J Med 350 (2004) 2151-2158
4. Desai A.S., Fang J.C., Maisel W.H., and Baughman K.L. Implantable defibrillators for the prevention of mortality in patients with nonischemic cardiomyopathy: a meta-analysis of randomized controlled trials. JAMA 292 (2004) 2874-2879
5. Schron E.B., Exner D.V., Yao Q., et al. Quality of life in the antiarrhythmics versus implantable defibrillators trial: impact of therapy and influence of adverse symptoms and defibrillator shocks. Circulation 105 (2002) 589-594
6. Namerow P.B., Firth B.R., Heywood G.M., Windle J.R., and Parides M.K. Quality-of-life six months after CABG surgery in patients randomized to ICD versus no ICD therapy: findings from the CABG Patch Trial. Pacing Clin Electrophysiol 22 (1999) 1305-1313
7. Poole J.E., Johnson G.W., Hellkamp A.S., et al. Prognostic importance of defibrillator shocks in patients with heart failure. N Engl J Med 359 (2008) 1009-1017
8. Bode-Schnurbus L., Bocker D., Block M., et al. QRS duration: a simple marker for predicting cardiac mortality in ICD patients with heart failure. Heart 89 (2003) 1157-1162
9. Stecker E.C., Zargarian M., Dogra V., et al. Native QRS duration predicts the occurrence of arrhythmic events in ICD recipients. Europace 8 (2006) 859-862
10. Huikuri H.V., Makikallio T.H., Raatikainen M.J., Perkiomaki J., Castellanos A., and Myerburg R.J. Prediction of sudden cardiac death: appraisal of the studies and methods assessing the risk of sudden arrhythmic death. Circulation 108 (2003) 110-115
11. Zecchin M., Di Lenarda A., Proclemer A., et al. The role of implantable cardioverter defibrillator for primary vs secondary prevention of sudden death in patients with idiopathic dilated cardiomyopathy. Europace 6 (2004) 400-406
12. Zecchin M., Di Lenarda A., Gregori D., et al. Prognostic role of non-sustained ventricular tachycardia in a large cohort of patients with idiopathic dilated cardiomyopathy. Ital Heart J 6 (2005) 721-727
13. Morgera T., Di Lenarda A., Sabbadini G., et al. Idiopathic dilated cardiomyopathy: prognostic significance of electrocardiographic and electrophysiologic findings in the nineties. Ital Heart J 5 (2004) 593-603
14. Grimm W., Christ M., Bach J., Muller H.H., and Maisch B. Noninvasive arrhythmia risk stratification in idiopathic dilated cardiomyopathy: results of the Marburg Cardiomyopathy Study. Circulation 108 (2003) 2883-2891
15. Hohnloser S.H., Klingenheben T., Bloomfield D., Dabbous O., and Cohen R.J. Usefulness of microvolt T-wave alternans for prediction of ventricular tachyarrhythmic events in patients with dilated cardiomyopathy: results from a prospective observational study. J Am Coll Cardiol 41 (2003) 2220-2224
16. Grimm W., Hoffmann J., Menz V., Luck K., and Maisch B. Programmed ventricular stimulation for arrhythmia risk prediction in patients with idiopathic dilated cardiomyopathy and nonsustained ventricular tachycardia. J Am Coll Cardiol 32 (1998) 739-745
17. Stevenson W.G., and Soejima K. Catheter ablation for ventricular tachycardia. Circulation 115 (2007) 2750-2760
18. Soejima K., Stevenson W.G., Sapp J.L., Selwyn A.P., Couper G., and Epstein L.M. Endocardial and epicardial radiofrequency ablation of ventricular tachycardia associated with dilated cardiomyopathy: the importance of low-voltage scars. J Am Coll Cardiol 43 (2004) 1834-1842
19. Juilliere Y., Marie P.Y., Danchin N., et al. Radionuclide assessment of regional differences in left ventricular wall motion and myocardial perfusion in idiopathic dilated cardiomyopathy. Eur Heart J 14 (1993) 1163-1169
20. Das M.K., Khan B., Jacob S., Kumar A., and Mahenthiran J. Significance of a fragmented QRS complex versus a Q wave in patients with coronary artery disease. Circulation 113 (2006) 2495-2501
21. Mahenthiran J., Khan B.R., Sawada S.G., and Das M.K. Fragmented QRS complexes not typical of a bundle branch block: a marker of greater myocardial perfusion tomography abnormalities in coronary artery disease. J Nucl Cardiol 14 (2007) 347-353
22. Varriale P., and Chryssos B.E. The RSR′ complex not related to right bundle branch block: diagnostic value as a sign of myocardial infarction scar. Am Heart J 123 (1992) 369-376
23. Peters S., Trummel M., and Koehler B. QRS fragmentation in standard ECG as a diagnostic marker of arrhythmogenic right ventricular dysplasia-cardiomyopathy. Heart Rhythm 5 (2008) 1417-1421
24. Morita H., Fukushima K., Miura D., et al. Fragmented QRS as a marker of conduction abnormality and a predictor of prognosis of Brugada syndrome. Circulation 118 (2008) 1697-1704
25. Das M.K., Saha C., El Masry H., et al. Fragmented QRS on a 12-lead ECG: a predictor of mortality and cardiac events in patients with coronary artery disease. Heart Rhythm 4 (2007) 1385-1392
26. Grambsch P. Proportional hazards tests and diagnostics based on weighted residuals. Biometrika 81 (1994) 515-526
27. Gomes J.A., Cain M.E., Buxton A.E., Josephson M.E., Lee K.L., and Hafley G.E. Prediction of long-term outcomes by signal-averaged electrocardiography in patients with unsustained ventricular tachycardia, coronary artery disease, and left ventricular dysfunction. Circulation 104 (2001) 436-441
28. Costantini O., Hohnloser S.H., Kirk M.M., et al. The ABCD (Alternans Before Cardioverter Defibrillator) trial: strategies using T-wave alternans to improve efficiency of sudden cardiac death prevention. J Am Coll Cardiol 53 (2009) 471-479
29. Chow T., Kereiakes D.J., Onufer J., et al. Does microvolt T-wave alternans testing predict ventricular tachyarrhythmias in patients with ischemic cardiomyopathy and prophylactic defibrillators?. The MASTER (Microvolt T Wave Alternans Testing for Risk Stratification of Post-Myocardial Infarction Patients) trial. J Am Coll Cardiol 52 (2008) 1607-1615
30. Gold M.R., Ip J.H., Costantini O., et al. Role of microvolt T-wave alternans in assessment of arrhythmia vulnerability among patients with heart failure and systolic dysfunction: primary results from the T-wave alternans sudden cardiac death in heart failure trial substudy. Circulation 118 (2008) 2022-2028
31. Flowers N.C., Horan L.G., Thomas J.R., and Tolleson W.J. The anatomic basis for high-frequency components in the electrocardiogram. Circulation 39 (1969) 531-539
32. Calore C., Cacciavillani L., Boffa G.M., et al. Contrast-enhanced cardiovascular magnetic resonance in primary and ischemic dilated cardiomyopathy. J Cardiovasc Med (Hagerstown) 8 (2007) 821-829
33. Homsi M., Alsayed L., Das M.K., and Mahenthiran J. Fragmented QRS complexes on a 12-lead ECG is a marker of greater myocardial scarring related to coronary artery disease by magnetic resonance imaging. J Am Coll Cardiol 51 (2008) A31
34. Homsi M., Alsayed L., Das M.K., and Mahenthiran J. Fragmented QRS complexes on a 12-lead ecg is a marker of greater myocardial scarringd related to non-coronary artery diseases by magnetic resonance imaging. J Am Coll Cardiol 53 (2009) A140
35. Wiener I., Mindich B., and Pitchon R. Fragmented endocardial electrical activity in patients with ventricular tachycardia: a new guide to surgical therapy. Am Heart J 107 (1984) 86-90
36. Roberts W.C., Siegel R.J., and McManus B.M. Idiopathic dilated cardiomyopathy: analysis of 152 necropsy patients. Am J Cardiol 60 (1987) 1340-1355
37. de Bakker J.M., van Capelle F.J., Janse M.J., et al. Slow conduction in the infarcted human heart. "Zigzag" course of activation. Circulation 88 (1993) 915-926
38. de Bakker J.M., van Capelle F.J., Janse M.J., et al. Fractionated electrograms in dilated cardiomyopathy: origin and relation to abnormal conduction. J Am Coll Cardiol 27 (1996) 1071-1078
39. Khan B.D.M., Jacob S., Kumar A., and Mahenthiran J. Quest for a sensitive sign of myocardial infarction: beyond Q wave. J Am Coll Cardiol 45 (2005) 206A
40. Ellenbogen K.A., Levine J.H., Berger R.D., et al. Are implantable cardioverter defibrillator shocks a surrogate for sudden cardiac death in patients with nonischemic cardiomyopathy?. Circulation 113 (2006) 776-782